Phenotype and biomarkers in patients who initiated biologics therapy stratified by oral corticosteroid use in the International Severe Asthma Registry
2024; Lippincott Williams & Wilkins; Linguagem: Inglês
10.1183/13993003.congress-2024.pa438
ISSN1531-5487
AutoresCarlos A. Torres-Duque, Jeffrey Shi Kai Chan, Kirsty Fletton, Jonathan N. Townend, Delbert R. Dorscheid, Alan Altraja, Charlotte Suppli Ulrik, Aaron Beastall, Celine Goh, Vidya Navaratnam, Lakmini Bulathsinhala, Victoria Carter, Zhixiao Wang, Rebecca Gall, Wei‐Han Cheng, Bernt Bøgvald Aarli, Céline Bergeron, Arnaud Bourdin, Adeeb A. Bulkhi, George Christoff, João Fonseca, Christine Jenkins, Mariko Siyue Koh, Κonstantinos Κostikas, Stelios Loukides, Roy A. Pleasants, Todor A. Popov, Dermot Ryan, Iván Solarte, Ming‐Ju Tsai, Libardo Jiménez-Maldonado, Piotr Kuna, Renaud Louis, Bassam Mahboub, Ruth Murray, Paulo Márcio Pitrez, Francesca Puggioni, Mona Al‐Ahmad, Leif Bjermer, Unnur Steina Björnsdóttir, Borja G. Cosío, Richard W. Costello, Zsuzsanna Csoma, Takashi Iwanaga, Désirée Larenas‐Linnemann, Lauri Lehtimäki, Martín Sívori, Chin Kook Rhee, Sundeep Salvi, Christian Taube, David Price,
Tópico(s)Asthma and respiratory diseases
Referência(s)